The MarketWatch News Department was not involved in the creation of this content.-- Newly discovered drug leverages the power of Pattern Discovery Engine(TM) (PDE) and is an exten ...

In his doctoral dissertation completed at the University of Jyväskylä, Finland, Tero Sievänen demonstrates that the cancer risk of Lynch syndrome carriers can be assessed based on circulating microRNA ...

This isn't the first time RNA has been honored recently. The molecule has been something of a scientific darling of late: last year, Katalin Kariko and Drew Weissman were awarded the Nobel Prize in ...

(Nanowerk Spotlight) Cancer treatments have traditionally involved a difficult balance between effectiveness and side effects. For skin cancers, this challenge is particularly pronounced. Researchers ...

Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish between harmless and aggressive forms of the disease. This review highlights how ...

A team led by Dr. Shiwei Duan (Department of Clinical Medicine, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China) analyzed literature on miRNA. Their work, summarizing the close ...

In his doctoral dissertation completed at the University of Jyväskylä, Finland, Tero Sievänen demonstrates that the cancer risk of Lynch syndrome carriers can be assessed based on circulating microRNA ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers identified two microRNA that may help ...

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.

American researchers Victor Ambros and Gary Ruvkun have been awarded the Nobel Prize in Physiology or Medicine. The Nobel Assembly at the Karolinska Institute, Sweden, announced the award on Monday.